Predicting Anti-VEGF Response in Diabetic Macular Edema

by Medscape • 2016/09/13 • 0 Comments

Response after 12 weeks of ranibizumab therapy can predict long-term outcomes in diabetic macular edema, a post hoc analysis suggests.
Medscape Medical News

Full Story →

← India CR39 Eyeglasses Market Forecasts to 2021 – High Prevalence of Impaired Vision and Increasing Awareness to Fuel Growth Featuring GKB Ophthalmics, Techtran Polylenses & Zeiss – Research and Markets

FDA Approves VisuMax Femtosecond Laser to Treat Myopia →

Post navigation